Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence.

Cancer research - 1 Dec 2006

Kahl Philip, Gullotti Lucia, Heukamp Lukas Carl, Wolf Susanne, Friedrichs Nicolaus, Vorreuther Roland, Solleder Gerold, Bastian Patrick J, Ellinger Jörg, Metzger Eric, Schüle Roland, Buettner Reinhard

Abstract excerpt

Prostate cancer biology varies from locally confined tumors with low risk for relapse to tumors with high risk for progression even after radical prostatectomy. Currently, there are no reliable biomarkers to predict tumor relapse and poor clinical outcome. In this study, we correlated expression patterns of the androgen receptor (AR) coactivators lysine-specific histone demethylase 1 (LSD1) and four and a half...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytoplasm
Share to Histone Demethylases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Kaplan-Meier Estimate

Share to LIM-Homeodomain Proteins

Share to Muscle Proteins

Share to Neoplasm Recurrence, Local

Share to Oxidoreductases, N-Demethylating

Share to Receptors, Androgen

Source

Identifiers

PMID: 17145880
DOI: 10.1158/0008-5472.CAN-06-1570

Genes

FHL2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence.PMID 17145880Read ↗

Global Levels of Specific Histone Modifications and an Epigenetic Gene Signature Predict Prostate Cancer Progression and DevelopmentSemantic proximity Read ↗

LSD1 Inhibition Disrupts Super-Enhancer–Driven Oncogenic Transcriptional Programs in Castration-Resistant Prostate CancerSemantic proximity Read ↗

Expression profiling of prostate cancer tissue delineates genes associated with recurrence after prostatectomySemantic proximity Read ↗

Gene expression profiling predicts clinical outcome of prostate cancerSemantic proximity Read ↗

Reduced NCOR2 expression accelerates androgen deprivation therapy failure in prostate cancerSemantic proximity Read ↗

Unveiling DENND2D as a Novel Prognostic Biomarker for Prostate Cancer Recurrence: From Gene to PrognosisSemantic proximity Read ↗

LSD1 activates a lethal prostate cancer gene network independently of its demethylase functionSemantic proximity Read ↗

Validation Study of Genes with Hypermethylated Promoter Regions Associated with Prostate Cancer RecurrenceSemantic proximity Read ↗

Epigenetic silencing of MEIS2 in prostate cancer recurrenceSemantic proximity Read ↗

NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesisSemantic proximity Read ↗

Increased MYBL2 expression in aggressive hormone‐sensitive prostate cancerSemantic proximity Read ↗

LSD1-Mediated Epigenetic Reprogramming Drives CENPE Expression and Prostate Cancer ProgressionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.